| Mr Arif Ullah Khan, MD | |
|
130 Fisher Rd, Central Vermont Hospital, Berlin, VT 05602-9516 | |
| (802) 223-6386 | |
| Not Available |
| Full Name | Mr Arif Ullah Khan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 130 Fisher Rd, Berlin, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447320627 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | (Vermont) | Primary |
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831374362 PECOS PAC ID: 9335138817 Enrollment ID: O20040510001034 |
News Archive
ViroStatics, a private Italian/American biopharmaceutical company developing novel therapeutics for viral and other chronic diseases, announced that a review of the first human clinical trial to test a new class of anti-HIV medications known as AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) has been published in the peer-reviewed journal PLoS ONE.
Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline.
A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.
An internationally recognized expert in viruses, Robert W. Finberg, MD, the Richard M. Haidack Professor of Medicine and chair and professor of medicine at the University of Massachusetts Medical School, is lead investigator on a $12 million project to develop new ways of predicting how the influenza virus changes and evolves in response to anti-viral drugs and the human immune system. This approach has promise for becoming a pivotal tool in creating a more effective vaccine against the virus.
› Verified 4 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
ViroStatics, a private Italian/American biopharmaceutical company developing novel therapeutics for viral and other chronic diseases, announced that a review of the first human clinical trial to test a new class of anti-HIV medications known as AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) has been published in the peer-reviewed journal PLoS ONE.
Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline.
A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.
An internationally recognized expert in viruses, Robert W. Finberg, MD, the Richard M. Haidack Professor of Medicine and chair and professor of medicine at the University of Massachusetts Medical School, is lead investigator on a $12 million project to develop new ways of predicting how the influenza virus changes and evolves in response to anti-viral drugs and the human immune system. This approach has promise for becoming a pivotal tool in creating a more effective vaccine against the virus.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Arif Ullah Khan, MD Po Box 547, Central Vermont Hospital, Barre, VT 05641 Ph: (802) 223-6386 | Mr Arif Ullah Khan, MD 130 Fisher Rd, Central Vermont Hospital, Berlin, VT 05602-9516 Ph: (802) 223-6386 |
News Archive
ViroStatics, a private Italian/American biopharmaceutical company developing novel therapeutics for viral and other chronic diseases, announced that a review of the first human clinical trial to test a new class of anti-HIV medications known as AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) has been published in the peer-reviewed journal PLoS ONE.
Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline.
A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.
An internationally recognized expert in viruses, Robert W. Finberg, MD, the Richard M. Haidack Professor of Medicine and chair and professor of medicine at the University of Massachusetts Medical School, is lead investigator on a $12 million project to develop new ways of predicting how the influenza virus changes and evolves in response to anti-viral drugs and the human immune system. This approach has promise for becoming a pivotal tool in creating a more effective vaccine against the virus.
› Verified 4 days ago
Laura Allen Felsted, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Ste 3, Mountainview Medical, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 | |
Devika Singh, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Mob-b Suite 3, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 | |
Brett Erdreich, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-371-4100 | |
Dr. Joachim Georg Mueller, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Cardiology Mob-a Suite 2-1, Berlin, VT 05602 Phone: 802-225-5660 Fax: 802-229-9533 | |
Sarah E Swift, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
Hannah Swayze-quinn, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
Peter Alan Redford, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 |